TL;DR – Quick Summary

  • High blood sugar causes nerve, eye, kidney, and blood vessel damage through glycation (AGE formation).
  • Benfotiamine (Vitamin B1) protects nerves and vessels from glucose damage.
  • Alpha-lipoic acid (ALA) improves insulin sensitivity, lowers cholesterol, and reduces inflammation.
  • Together, they may prevent and reduce diabetic neuropathy and protect organs.
  • Study dosages: Benfotiamine 400–1000 mg/day, ALA 600–800 mg/day.

The Problem with High Blood Sugar

Chronically high blood sugar damages the eyes, kidneys, blood vessels, and peripheral nerves, leading to diabetic neuropathy.

One major cause is glycation—when sugar molecules bind to proteins and form advanced glycation end products (AGEs). These harmful compounds accelerate aging, oxidative stress, and tissue damage.

The first step is controlling blood sugar and insulin naturally (guide to balancing blood sugar). But supplements like benfotiamine and alpha-lipoic acid add an extra layer of long-term protection.

Benfotiamine: A Potent Form of Vitamin B1

Benfotiamine is a fat-soluble vitamin B1 that’s absorbed more efficiently than standard thiamine.

Benefits for Diabetic Neuropathy

Clinical studies show benfotiamine supplementation reduces nerve pain, numbness, and tingling in people with diabetes.

Key Actions:

  • Shields nerves from glucose-induced injury
  • Reduces AGE formation
  • Supports vascular and kidney health

Research doses: 400–1000 mg/day

Learn more: Benfotiamine dosage and benefits.

Alpha-Lipoic Acid: Antioxidant and Metabolic Support

Alpha-lipoic acid (ALA) is a powerful antioxidant that supports both glucose metabolism and cholesterol balance.

Metabolic Benefits

·  Improves insulin sensitivity

·  Lowers LDL (“bad”) cholesterol

·  Reduces triglycerides

·  Decreases inflammation

Neuropathy Relief

At 600–800 mg/day, ALA has been shown to:

·  Relieve burning, tingling, and pain from diabetic neuropathy

·  Improve autonomic nerve function

·  Support heart health in type 2 diabetes

Study protocols:

·  IV: 600 mg/day for 3 weeks

·  Oral: 800 mg/day for 4 months

The Power of Combining Benfotiamine and Alpha-Lipoic Acid

Taken together, these two supplements protect nerves, vessels, and organs from glycation-related damage.

Why the Combination Works

  • Benfotiamine: lowers AGE formation and strengthens nerve health
  • Alpha-lipoic acid: improves sugar metabolism and reduces oxidative stress

Research findings:

  • Normalizes harmful AGE levels
  • Reduces inflammatory protein changes by 40%
  • Restores vascular enzyme function

Benfotiamine + Alpha-Lipoic Acid FAQ

1. What do they do?
Together, they protect against nerve damage, blood vessel injury, and organ complications caused by high blood sugar.

2. Can they help diabetic neuropathy?
Yes. Studies show both supplements reduce pain, numbness, and tingling while improving nerve function.

3. What’s the recommended dosage?

  • Benfotiamine: 400–600 mg/day
  • Alpha-lipoic acid: 600–800 mg/day (split into two doses)

4. Are there side effects?
Generally safe. Some may experience digestive upset, rash, or dizziness. Check with your healthcare provider if you take medications.

5. How long before results?
Some see improvements in a few weeks, but 2–3 months of consistent use is often needed for full benefits.

6. Can I take them with other medications?
Yes, but consult your healthcare provider—especially if you’re on diabetes or blood pressure medications.

Sources

  1. BMJ Open. 2022 Feb 3;12(2):e057142. Benfotiamine in the treatment of diabetic polyneuropathy–a three-week randomized, controlled pilot study (BEDIP study)
  2. Int J Clin Pharmacol Ther. 2005 Feb;43(2):71-7 BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
  3. J Diabetes Complications. 2020 Dec;34(12):107757. Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months
  4. Obesity (Silver Spring). 2011 Aug;19(8):1647-53 Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects
  5. Metabolism. 2018 Oct;87:56-69 The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
  6. J Int Med Res. 2018 May;46(5):1779-1790 Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy
  7. Diabetes. 1997 Sep;46 Suppl 2:S62-6 Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy
  8. Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2706-9 [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study]
  9. Drugs R D. 2012 Mar 1;12(1):29-34 Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy
  10. Exp Clin Endocrinol Diabetes. 2000;108(3):168-74 Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy
  11. Diabetologia. 1995 Dec;38(12):1425-33 Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)
  12. Free Radic Res. 1999 Sep;31(3):171-9 Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
  13. Diabetologia. 2008 Oct;51(10):1930-2. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes